OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria

New antimicrobial agents are urgently needed, especially to eliminate multidrug resistant Gram-negative bacteria that stand for most antibiotic-resistant threats. In the following study, we present superior properties of an engineered antimicrobial peptide, OMN6, a 40-amino acid cyclic peptide based...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandel, Shira, Michaeli, Janna, Nur, Noa, Erbetti, Isabelle, Zazoun, Jonathan, Ferrari, Livia, Felici, Antonio, Cohen-Kutner, Moshe, Bachnoff, Niv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988117/
https://www.ncbi.nlm.nih.gov/pubmed/33758343
http://dx.doi.org/10.1038/s41598-021-86155-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988117/
https://www.ncbi.nlm.nih.gov/pubmed/33758343
http://dx.doi.org/10.1038/s41598-021-86155-9

Ejemplares similares